AUS
NZ
UK
CA
USA
IND
Healthcare
EAR to DOV: US stocks to explore as FDA paves way for OTC hearing aids
August 18, 2022 03:05 AM PDT| By Mridul GogoiExploring performances of 5 hearing aid stocks-EAR, KN, SPB, ENR, DOV
2 top healthcare stocks to watch in August: MRNA and MCK
August 02, 2022 04:55 AM PDT| By Mridul GogoiAmid volatile market conditions, healthcare stocks can be a viable option to balance out portfolios.
ABBV and AZN: Why are these US medical stocks trending hot?
July 29, 2022 07:23 AM PDT| By Rupam RoyAbbVie Inc (ABBV) and AstraZeneca PLC (AZN) have reported their second quarter earnings on Friday.
PFE and MRK: 2 top healthcare stocks to watch following Q2 results
July 28, 2022 11:59 AM PDT| By Mridul GogoiWith healthcare companies like Pfizer, Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) releasing their latest quarterly reports this week, the market also seems to be moving in tandem.
2 stocks to watch amid rising monkeypox fears: SIGA & TNXP
July 25, 2022 11:56 AM PDT| By Mridul GogoiTwo pharma stocks to explore as moneypox disease is spreading across the world.
2 US penny healthcare stocks to explore in August: REVB and GOVX
July 25, 2022 08:03 AM PDT| By Rupam RoyStocks of Revelation Biosciences, Inc. (NASDAQ: REVB) and GeoVax Labs, Inc. (NASDAQ: GOVX) have been creating a buzz on the stock markets on Monday, July 25, amid multiple developments.
5 top US dividend health stocks to explore: ABBV, CAH, OGN, AMGN, MRK
July 20, 2022 02:02 PM PDT| By Rupam RoyThe US healthcare sector has gained significant attention recently, with a notable number of investors exploring health stocks amid rising monkeypox cases worldwide.
Abbott Laboratories (ABT) raises EPS guidance; stock falls 1.2%
July 20, 2022 09:07 AM PDT| By Versha JainAbbott Laboratories (ABT) sales rose 10.1% YoY, company raises EPS guidance.
Neuronetics, Inc. (STIM) stock rallied 12% on getting FDA clearance
July 19, 2022 09:02 AM PDT| By Versha JainHighlights:,Malvern, Pennsylvania-based Neuronetics Inc is focused on developing products to treat patients with psychiatric disorders.,Today, it announced getting clearance from the US Food and Drug Administration (FDA) for a new indication of its N...
Bioscience Inc. (VIVO) agrees to US$1.5 Bn buyout deal
July 08, 2022 07:35 AM PDT| By Mridul GogoiBioscience Inc. (Nasdaq: VIVO) concedes to US$1.5 Bn buyout deal by Seoul-based device maker SD Biosensor Inc. for US$1.53 billion.
NBIX to ITCI: Five mid-cap healthcare stocks to watch in July
July 04, 2022 01:33 PM PDT| By Versha JainHealthcare sector has been in good stead and shown resilience in a bearish market.
NeuroSense (NRSN) stock soars 35% after Alzheimer's study results
June 30, 2022 09:51 AM PDT| By Versha JainNeuroSense stock soared over 35% on Thursday after study results showing potential of its drug combination for Alzheimer's treatment.
Kezar (KZR) stock soars 49% on positive lupus trial results
June 28, 2022 11:31 AM PDT| By Versha JainKezar (KZR) stock soared on the positive top-line data from Mission phase 2 clinical trial.
Acutus (AFIB) stock zooms 100% after FDA clearance
June 27, 2022 09:37 AM PDT| By Versha JainAcutus stock jumped on Monday after getting FDA clearance.
Novartis AG (NVS) stock rises after FDA’s accelerated drug approval
June 23, 2022 09:13 AM PDT| By Versha JainNovartis AG received FDA's accelerated approval for the combination of its two drugs, Tafinlar and Mekinist as first tumor-agnostic indication.
Seagen (SGEN) stock roared 17% higher on Merck’s (MRK) buyout plan
June 17, 2022 11:37 AM PDT| By Versha JainHighlights: Washington-based Seagen Inc. (NASDAQ: SGEN) stock rose 16.76% on Friday. Merck & Company, Inc. (MRK) is considering buying the biotech firm. However, their talks are not yet conclusive. Washington-based Seagen Inc. (.....
Cogent Biosciences (COGT) stock soars 101% on positive trial data
June 10, 2022 11:45 AM PDT| By Versha JainHighlights: Cogent Biosciences, Inc. (NASDAQ: COGT) develops therapies for genetic diseases. The company went public on March 26, 2018. On Friday, it reported positive Phase 2 clinical trial data for ‘Bezuclastinib’. Sha.....
Top healthcare stocks to explore in June: JNJ, LLY, ABBV, MRK & BMY
June 09, 2022 04:38 PM PDT| By Rupam RoyHighlights: Johnson & Johnson (NYSE: JNJ) revenue increased by 5% YoY in Q1, FY22. Merck & Company, Inc. (NYSE: MRK) revenue rose 50% YoY in Q1, FY22. Bristol-Myers Squibb Company (NYSE: BMY) stock returned over 21% gains YTD. The.....
Becton, Dickinson & Co (BDX) to acquire Parata Systems for US$1.525 bn
June 06, 2022 10:08 AM PDT| By Mridul GogoiHighlights: Becton, Dickinson & Company or BD (NYSE: BDX) to acquire Parata Systems for US$1.525 billion. The deal is likely to close by the end of the first half of fiscal 2023 for BD. The pharmacy automation market is set to grow approxi.....
Turning Point (TPTX) stock zooms 115% on Bristol Myers’ (BMY) acquisition
June 03, 2022 11:31 AM PDT| By Versha JainHighlights Turning Point Therapeutics, Inc. (TPTX) is focused on precision oncology therapy. It was founded in 2013 and launched its IPO in April 2019. Bristol Myers Squibb is acquiring Turning Point for US$4.1 billion in equity va.....
